— Know what they know.
Not Investment Advice
Also trades as: MED.SW (SIX) · $vol 1M

MDRSF OTC

Medartis Holding AG
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +15.0% 1Y: +72.5% 3Y: +94.9% 5Y: +140.8%
$115.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 46 · $1.4B mcap · 4M float · 0.0045% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$35M +8.6% ▲
5Y CAGR: +22.5%
Capital Expenditures
$25M -129.7% ▼
5Y CAGR: +14.3%
Free Cash Flow
$9M -55.5% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$106M -193.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$7M-$6M$619K$4M$9M
Depreciation & Amort.$16M$18M$23M$22M$25M
Stock-Based Comp.$2M$2M$1M$966K$2M
Change in Working Capital-$6M-$19M$3M-$7M$10M
Other Non-Cash Items$1M-$2M-$7M$13M-$11M
Operating Cash Flow$21M-$4M$20M$32M$35M
— Investing Activities —
Capital Expenditures-$10M-$19M-$15M-$7M-$19M
Acquisitions (Net)$66K-$36M-$20M-$9M-$109M
Investment Purchases-$6M-$4M$0$0-$59K
Investment Sales$8M$5M$0$0$0
Other Investing-$8M$1K-$3M-$3M-$19M
Investing Cash Flow-$16M-$53M-$38M-$19M-$146M
— Financing Activities —
Net Debt Issuance-$6K$0-$463K$111M$20M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$5M-$4M-$6M-$12M-$13M
Financing Cash Flow-$5M-$4M$23M$101M$7M
Net Change in Cash-$93K-$62M$5M$113M-$106M
Cash End of Period$83M$21M$25M$139M$33M
Free Cash Flow$11M-$23M$1M$21M$9M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms